22Nd Cent (XXII) 2.39 $XXII
Patents Granted For 22nd Century Group's Technology to Virtually Eliminate Nicotine in Tobacco Plants
Business Wire - Wed Jul 30, 6:48AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that the U.S. Patent and Trademark Office (USPTO) on July 29, 2014 and the Korean Intellectual Property Office on July 23, 2014, each granted a patent to the Company for its NBB technology that virtually eliminates nicotine in the tobacco plant. The resulting tobacco plants are planted, grown, harvested, cured, processed, and made into tobacco products, including cigarettes, exactly the same as conventional tobacco.
22nd Century Group Engages CRO for FDA Regulatory Activities of Company's Modified Risk Cigarettes
Business Wire - Fri Jul 11, 11:44AM CDT
22nd Century Group, Inc. (NYSE MKT: XXII) announced today that it has engaged a major a contract research organization ("CRO"
with extensive experience in tobacco exposure studies to assist the Company in certain regulatory activities at the Center for Tobacco Products ("CTP" of the U.S. Food and Drug Administration ("FDA" related to the Company's research to support the development of potentially less harmful or modified risk cigarettes.
22nd Century Group Announces Allowance of U.S. Patent For Regulating Nicotine in Tobacco Using Transcription Factor Gene
Business Wire - Thu Jul 03, 7:50AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for technology that decreases or increases nicotine production and levels in tobacco plants by using nucleic acids derived from a transcription factor gene identified as NbTF7 - also known as NbARF1. NbTF7 simultaneously regulates the expression of multiple nicotine biosynthesis genes.
22nd Century Group Added to Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes
Business Wire - Mon Jun 30, 1:20PM CDT
22nd Century Group, Inc. (NYSE MKT: XXII) today announced that the Company joined the Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes on June 27, 2014 when Russell Investments (Russell) reconstituted its U.S. and global equity indexes.
Consumer Staples Stocks Review -- Research on Altria, Darling Ingredients, Elizabeth Arden, and 22nd Century
PR Newswire - Thu Jun 26, 5:50AM CDT
On Wednesday, June 25, 2014, the NASDAQ Composite ended at 4,379.76, up 0.68%, the Dow Jones Industrial Average finished the day 0.29% higher at 16,867.51, and the S&P 500 closed at 1,959.53, up 0.49%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Consumer Staples Sector Index ended the day at 460.66, down 0.06%, while the index has advanced 1.47% in the last one month. Investor-Edge has initiated coverage on the following equities: Altria Group Inc. (NYSE: MO), Darling Ingredients Inc. (NYSE: DAR), Elizabeth Arden Inc. (NASDAQ: RDEN) and 22nd Century Group Inc. (NYSE MKT: XXII). Free technical research on MO, DAR, RDEN and XXII can be downloaded upon signing up at:
4 Biotech Stocks Under $10 to Watch for Breakout Trades
at The Street - Fri Jun 20, 7:27AM CDT
These biotech stocks trading for under $10 are starting to push higher into breakout territory.
22nd Century Group to be Added to Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes
Business Wire - Mon Jun 16, 4:45AM CDT
22nd Century Group, Inc. (NYSE MKT: XXII) today announced that the Company will join the Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes when Russell Investments (Russell) reconstitutes its U.S. and global equity indexes on June 27, 2014. Russell's announcement of its annual reconstitution of these Russell indexes, which included 22nd Century Group, was listed on the Russell website on Friday, June 13, 2014, after the U.S. stock market closed.
22nd Century Group expects US patent for technology that regulates nicotine levels in tobacco
M2 - Thu Jun 12, 7:53AM CDT
Plant biotechnology company 22nd Century Group (NYSE MKT:XXII) disclosed on Wednesday the receipt of the US Patent and Trademark Office's (USPTO) Notice of Allowance for technology that reduces nicotine in tobacco by suppressing expression of the NBB gene by itself and in combination with other nicotine biosynthesis genes.
U.S. Patent Allowed For 22nd Century Group's Technology to Regulate Nicotine Levels in Tobacco
Business Wire - Wed Jun 11, 12:40PM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that on June 9, 2014 the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance to the Company for technology that reduces nicotine in tobacco by suppressing expression of the NBB gene by itself and in combination with other nicotine biosynthesis genes.
22nd Century Group Signs Letter of Intent With European Factory For Production of Nicotine-Free Tobacco Cigarettes in Europe
Business Wire - Thu May 29, 6:15AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that its subsidiary, Goodrich Tobacco Company LLC, signed a letter of intent with Orion, a cigarette manufacturer based in Poland, to contract manufacture the Company's proprietary tobacco products to be distributed in the European Union.
22nd Century Group to Present at Institutional Investor Conference as Part of National Road Show
Business Wire - Wed May 28, 6:15AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that Henry Sicignano III, President, will present at the LD MICRO Invitational Conference at the Luxe Sunset Hotel, Los Angeles, California, on Wednesday, June 4th, 2014 at 9:00am PDT.
22nd Century Group Eliminates $7.7 Million of Warrant Liability
Business Wire - Tue Apr 01, 7:12AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that the Company entered into warrant amendments yesterday with existing warrant holders to eliminate virtually all of the Company's "derivative warrant liability." 22nd Century Group had previously issued certain warrants that contained anti-dilution provisions.
Symantec Corporation Upgraded by BMO Capital Markets to Out Perform; Procter & Gamble is Dow's Top Performing Stock Monday
ACCESSWIRE - Mon Mar 24, 11:23PM CDT
The Procter & Gamble Company (NYSE: PG) - For an in-depth report on The Procter & Gamble Company follow: www.BullTrends.com/stockquote/PG
Equities Briefing on Top Gainers -- Research on Tower Semiconductor, BioFuel Energy, Flotek Industries and 22nd Century Group
PR Newswire - Fri Mar 21, 8:55AM CDT
The US markets saw a positive sentiment on Thursday, March 20, 2014, with the NASDAQ Composite closing at 4,319.29, up 0.27%, the Dow Jones Industrial Average ending the session at 16,331.05, up 0.67% and the S&P 500 edging 0.60% higher to finish the trading session at 1,872.01. During the session, gains in the Information Technology, Financials, and Telecommunication Services sectors positively impacted the broader market. A number of stocks saw large movements, including Tower Semiconductor Ltd (NASDAQ: TSEM), BioFuel Energy Corp. (NASDAQ: BIOF), Flotek Industries Inc. (NYSE: FTK) and 22nd Century Group Inc. (NYSEMKT: XXII). Free technical research on TSEM, BIOF, FTK and XXII can be downloaded upon signing up at:
22nd Century Group Subsidiary Goodrich Tobacco Company Granted Federal Permit to Manufacture Tobacco Products
Business Wire - Mon Mar 10, 6:44AM CDT
22nd Century Group, Inc. (OTCQB: XXII) today announced that its wholly owned subsidiary, Goodrich Tobacco Company, has been granted a federal permit to produce tobacco products by the Alcohol and Tobacco Tax and Trade Bureau of the U.S. Department of the Treasury ("TTB Permit".
321GoStock Early Morning Risers OTCQB XXII 22nd century group share prices Rises on approval for NYSE MKT listing
M2 - Fri Mar 07, 9:09AM CST
Vancouver (321GoStocks) Mar 07, 2014 22nd Century Group, Inc. (OTCQB:XXII) yesterday announced that the Company received approval to list its common stock on the NYSE MKT. Trading on the NYSE MKT is expected to commence on Tuesday, March 11, 2014 under the Company's current symbol, XXII. In connection with this NYSE MKT listing, 22nd Century Group will cease trading on the OTCBB and OTCQB.
22nd Century Group to list common stock on NYSE MKT under the ticker symbol XXII
M2 - Fri Mar 07, 4:46AM CST
Plant biotechnology company 22nd Century Group (OTCQB:XXII) said on Thursday that it will list its common stock on the NYSE MKT following approval.
22nd Century Group Approved to List Common Stock on NYSE MKT
Business Wire - Thu Mar 06, 4:30PM CST
22nd Century Group, Inc. (OTCQB:XXII) today announced that the Company received approval to list its common stock on the NYSE MKT. Trading on the NYSE MKT is expected to commence on Tuesday, March 11, 2014 under the Company's current symbol, XXII. In connection with this NYSE MKT listing, 22nd Century Group will cease trading on the OTCBB and OTCQB.
SDRL - Mandatory notification of trade
Thomson Reuters ONE - Fri Feb 28, 1:32AM CST
Hamilton, Bermuda, February 28, 2014 - Seadrill Limited ("Seadrill" has entered into a new Total Return Swap agreement (TRS) with DNB Bank ASA ("DNB" expiring on June 3, 2014 with 1,600,000 common shares in Seadrill Limited as underlying security. The reference price for the trade is NOK220.0739 per share.
22nd Century Group Files For NYSE MKT Listing and NASDAQ Capital Market Listing
Business Wire - Tue Feb 11, 6:20AM CST
22nd Century Group, Inc. (OTCQB: XXII) today announced that the Company last week submitted documentation to the New York Stock Exchange ("NYSE" and answered questions pursuant to an initial request letter as a first step toward filing a formal application for listing its common shares on NYSE MKT.
Patents Granted For 22nd Century Group's Technology to Virtually Eliminate Nicotine in Tobacco Plants
Business Wire - Wed Jul 30, 6:48AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that the U.S. Patent and Trademark Office (USPTO) on July 29, 2014 and the Korean Intellectual Property Office on July 23, 2014, each granted a patent to the Company for its NBB technology that virtually eliminates nicotine in the tobacco plant. The resulting tobacco plants are planted, grown, harvested, cured, processed, and made into tobacco products, including cigarettes, exactly the same as conventional tobacco.
22nd Century Group Engages CRO for FDA Regulatory Activities of Company's Modified Risk Cigarettes
Business Wire - Fri Jul 11, 11:44AM CDT
22nd Century Group, Inc. (NYSE MKT: XXII) announced today that it has engaged a major a contract research organization ("CRO"
with extensive experience in tobacco exposure studies to assist the Company in certain regulatory activities at the Center for Tobacco Products ("CTP" of the U.S. Food and Drug Administration ("FDA" related to the Company's research to support the development of potentially less harmful or modified risk cigarettes. 22nd Century Group Announces Allowance of U.S. Patent For Regulating Nicotine in Tobacco Using Transcription Factor Gene
Business Wire - Thu Jul 03, 7:50AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for technology that decreases or increases nicotine production and levels in tobacco plants by using nucleic acids derived from a transcription factor gene identified as NbTF7 - also known as NbARF1. NbTF7 simultaneously regulates the expression of multiple nicotine biosynthesis genes.
22nd Century Group Added to Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes
Business Wire - Mon Jun 30, 1:20PM CDT
22nd Century Group, Inc. (NYSE MKT: XXII) today announced that the Company joined the Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes on June 27, 2014 when Russell Investments (Russell) reconstituted its U.S. and global equity indexes.
Consumer Staples Stocks Review -- Research on Altria, Darling Ingredients, Elizabeth Arden, and 22nd Century
PR Newswire - Thu Jun 26, 5:50AM CDT
On Wednesday, June 25, 2014, the NASDAQ Composite ended at 4,379.76, up 0.68%, the Dow Jones Industrial Average finished the day 0.29% higher at 16,867.51, and the S&P 500 closed at 1,959.53, up 0.49%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Consumer Staples Sector Index ended the day at 460.66, down 0.06%, while the index has advanced 1.47% in the last one month. Investor-Edge has initiated coverage on the following equities: Altria Group Inc. (NYSE: MO), Darling Ingredients Inc. (NYSE: DAR), Elizabeth Arden Inc. (NASDAQ: RDEN) and 22nd Century Group Inc. (NYSE MKT: XXII). Free technical research on MO, DAR, RDEN and XXII can be downloaded upon signing up at:
4 Biotech Stocks Under $10 to Watch for Breakout Trades
at The Street - Fri Jun 20, 7:27AM CDT
These biotech stocks trading for under $10 are starting to push higher into breakout territory.
22nd Century Group to be Added to Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes
Business Wire - Mon Jun 16, 4:45AM CDT
22nd Century Group, Inc. (NYSE MKT: XXII) today announced that the Company will join the Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes when Russell Investments (Russell) reconstitutes its U.S. and global equity indexes on June 27, 2014. Russell's announcement of its annual reconstitution of these Russell indexes, which included 22nd Century Group, was listed on the Russell website on Friday, June 13, 2014, after the U.S. stock market closed.
22nd Century Group expects US patent for technology that regulates nicotine levels in tobacco
M2 - Thu Jun 12, 7:53AM CDT
Plant biotechnology company 22nd Century Group (NYSE MKT:XXII) disclosed on Wednesday the receipt of the US Patent and Trademark Office's (USPTO) Notice of Allowance for technology that reduces nicotine in tobacco by suppressing expression of the NBB gene by itself and in combination with other nicotine biosynthesis genes.
U.S. Patent Allowed For 22nd Century Group's Technology to Regulate Nicotine Levels in Tobacco
Business Wire - Wed Jun 11, 12:40PM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that on June 9, 2014 the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance to the Company for technology that reduces nicotine in tobacco by suppressing expression of the NBB gene by itself and in combination with other nicotine biosynthesis genes.
22nd Century Group Signs Letter of Intent With European Factory For Production of Nicotine-Free Tobacco Cigarettes in Europe
Business Wire - Thu May 29, 6:15AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that its subsidiary, Goodrich Tobacco Company LLC, signed a letter of intent with Orion, a cigarette manufacturer based in Poland, to contract manufacture the Company's proprietary tobacco products to be distributed in the European Union.
22nd Century Group to Present at Institutional Investor Conference as Part of National Road Show
Business Wire - Wed May 28, 6:15AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that Henry Sicignano III, President, will present at the LD MICRO Invitational Conference at the Luxe Sunset Hotel, Los Angeles, California, on Wednesday, June 4th, 2014 at 9:00am PDT.
22nd Century Group Eliminates $7.7 Million of Warrant Liability
Business Wire - Tue Apr 01, 7:12AM CDT
22nd Century Group, Inc. (NYSE MKT:XXII) today announced that the Company entered into warrant amendments yesterday with existing warrant holders to eliminate virtually all of the Company's "derivative warrant liability." 22nd Century Group had previously issued certain warrants that contained anti-dilution provisions.
Symantec Corporation Upgraded by BMO Capital Markets to Out Perform; Procter & Gamble is Dow's Top Performing Stock Monday
ACCESSWIRE - Mon Mar 24, 11:23PM CDT
The Procter & Gamble Company (NYSE: PG) - For an in-depth report on The Procter & Gamble Company follow: www.BullTrends.com/stockquote/PG
Equities Briefing on Top Gainers -- Research on Tower Semiconductor, BioFuel Energy, Flotek Industries and 22nd Century Group
PR Newswire - Fri Mar 21, 8:55AM CDT
The US markets saw a positive sentiment on Thursday, March 20, 2014, with the NASDAQ Composite closing at 4,319.29, up 0.27%, the Dow Jones Industrial Average ending the session at 16,331.05, up 0.67% and the S&P 500 edging 0.60% higher to finish the trading session at 1,872.01. During the session, gains in the Information Technology, Financials, and Telecommunication Services sectors positively impacted the broader market. A number of stocks saw large movements, including Tower Semiconductor Ltd (NASDAQ: TSEM), BioFuel Energy Corp. (NASDAQ: BIOF), Flotek Industries Inc. (NYSE: FTK) and 22nd Century Group Inc. (NYSEMKT: XXII). Free technical research on TSEM, BIOF, FTK and XXII can be downloaded upon signing up at:
22nd Century Group Subsidiary Goodrich Tobacco Company Granted Federal Permit to Manufacture Tobacco Products
Business Wire - Mon Mar 10, 6:44AM CDT
22nd Century Group, Inc. (OTCQB: XXII) today announced that its wholly owned subsidiary, Goodrich Tobacco Company, has been granted a federal permit to produce tobacco products by the Alcohol and Tobacco Tax and Trade Bureau of the U.S. Department of the Treasury ("TTB Permit"
. 321GoStock Early Morning Risers OTCQB XXII 22nd century group share prices Rises on approval for NYSE MKT listing
M2 - Fri Mar 07, 9:09AM CST
Vancouver (321GoStocks) Mar 07, 2014 22nd Century Group, Inc. (OTCQB:XXII) yesterday announced that the Company received approval to list its common stock on the NYSE MKT. Trading on the NYSE MKT is expected to commence on Tuesday, March 11, 2014 under the Company's current symbol, XXII. In connection with this NYSE MKT listing, 22nd Century Group will cease trading on the OTCBB and OTCQB.
22nd Century Group to list common stock on NYSE MKT under the ticker symbol XXII
M2 - Fri Mar 07, 4:46AM CST
Plant biotechnology company 22nd Century Group (OTCQB:XXII) said on Thursday that it will list its common stock on the NYSE MKT following approval.
22nd Century Group Approved to List Common Stock on NYSE MKT
Business Wire - Thu Mar 06, 4:30PM CST
22nd Century Group, Inc. (OTCQB:XXII) today announced that the Company received approval to list its common stock on the NYSE MKT. Trading on the NYSE MKT is expected to commence on Tuesday, March 11, 2014 under the Company's current symbol, XXII. In connection with this NYSE MKT listing, 22nd Century Group will cease trading on the OTCBB and OTCQB.
SDRL - Mandatory notification of trade
Thomson Reuters ONE - Fri Feb 28, 1:32AM CST
Hamilton, Bermuda, February 28, 2014 - Seadrill Limited ("Seadrill"
has entered into a new Total Return Swap agreement (TRS) with DNB Bank ASA ("DNB" expiring on June 3, 2014 with 1,600,000 common shares in Seadrill Limited as underlying security. The reference price for the trade is NOK220.0739 per share. 22nd Century Group Files For NYSE MKT Listing and NASDAQ Capital Market Listing
Business Wire - Tue Feb 11, 6:20AM CST
22nd Century Group, Inc. (OTCQB: XXII) today announced that the Company last week submitted documentation to the New York Stock Exchange ("NYSE"
and answered questions pursuant to an initial request letter as a first step toward filing a formal application for listing its common shares on NYSE MKT. 
